PDS Biotechnology Corporation

NASDAQ:PDSB

Biotechnology

Healthcare
$0.92 +1.21%

+$0.01 today

Market cap
$51.58M
Beta
1.56
P/E (TTM)
-1.5
EPS (TTM)
-$0.60
52W Low $0.51High $1.67

Volume 5.25M

Average 1.04M

Balance Sheet

Inspect the capital base behind the business.

Assets

$30.49M

FY 2025 · Annual

-32.8% YoY

Liabilities

$21.24M

FY 2025 · Annual

-19.4% YoY

Equity

$9.25M

FY 2025 · Annual

-51.3% YoY

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents65.24M73.82M56.56M41.69M26.71M
Short-term Investments00000
Net Receivables00000
Inventory00000
Other Current Assets02.66M2.49M3.36M1.54M
Total Current Assets66.84M76.48M59.06M45.05M28.25M
Property, Plant & Equipment (Net)357.7K527.53K335.01K304.21K243.7K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets00002M
Total Non-current Assets357.7K527.53K335.01K304.21K2.24M
Total Assets67.2M77.01M59.39M45.36M30.49M
Account Payables1.31M1.22M6.98M1.68M3.57M
Short-term Debt004.17M12.5M5.13M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities729.39K1.84M1.29M663.4K271.74K
Total Current Liabilities3.76M9.82M13.63M17.09M9.48M
Long-term Debt023.02M19.51M9.2M11.73M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities231.43K23.18M19.63M9.27M11.76M
Total Liabilities3.99M33.01M33.26M26.35M21.24M
Common Stock9.39K9.96K10.92K12.54K18.11K
Retained Earnings(60.7M)(101.56M)(144.5M)(182.11M)(216.61M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity63.21M44M26.13M19M9.25M
Total Debt490.35K23.47M23.85M21.83M16.93M
Net Debt(64.75M)(50.35M)(32.71M)(19.86M)(9.79M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$21.7M
Other Current$1.2M
Total Current Assets$22.9M
PP&E (Net)$228.6K
Other Non-current$1.5M
Total Non-current Assets$1.8M
Total Assets$24.7M

Analysis

Selected assets total $24.7M for Latest. The largest visible component is Cash & Equivalents at $21.7M, about 87.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipOct 21, 2026
8-KCurrent reportOct 21, 2026
3Initial statement of beneficial ownershipOct 21, 2026
3Initial statement of beneficial ownershipOct 20, 2026
4Statement of changes in beneficial ownershipOct 20, 2026

How much cash does PDSB have?

PDS Biotechnology Corporation (PDSB) reported $26.71M in cash and equivalents in fiscal 2025.

How much debt does PDSB carry?

PDS Biotechnology Corporation (PDSB) reported $16.93M of total debt, with net debt of -$9.79M.